A detailed history of Amalgamated Bank transactions in Novavax Inc stock. As of the latest transaction made, Amalgamated Bank holds 4,887 shares of NVAX stock, worth $45,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,887
Previous 4,887 -0.0%
Holding current value
$45,693
Previous $62,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$3.89 - $20.97 $4,030 - $21,724
1,036 Added 26.9%
4,887 $62,000
Q1 2024

Apr 23, 2024

SELL
$3.76 - $6.02 $27,936 - $44,728
-7,430 Reduced 65.86%
3,851 $18,000
Q4 2023

Feb 06, 2024

SELL
$4.8 - $7.67 $3,931 - $6,281
-819 Reduced 6.77%
11,281 $54,000
Q2 2023

Aug 11, 2023

SELL
$6.67 - $9.52 $34,637 - $49,437
-5,193 Reduced 30.03%
12,100 $89,000
Q1 2023

May 02, 2023

SELL
$5.76 - $12.48 $2,016 - $4,368
-350 Reduced 1.98%
17,293 $120,000
Q3 2022

Nov 09, 2022

BUY
$18.2 - $76.12 $3,640 - $15,224
200 Added 1.15%
17,643 $321,000
Q2 2022

Aug 15, 2022

SELL
$36.28 - $75.29 $3,736 - $7,754
-103 Reduced 0.59%
17,443 $897,000
Q1 2022

Jun 30, 2022

BUY
$69.73 - $142.9 $109,197 - $223,781
1,566 Added 9.8%
17,546 $1.29 Million
Q4 2021

Feb 15, 2022

BUY
$134.56 - $217.97 $196,323 - $318,018
1,459 Added 10.05%
15,980 $2.29 Million
Q3 2021

Oct 29, 2021

SELL
$177.8 - $270.58 $145,084 - $220,793
-816 Reduced 5.32%
14,521 $3.01 Million
Q2 2021

Aug 16, 2021

BUY
$121.0 - $257.67 $1.13 Million - $2.41 Million
9,340 Added 155.74%
15,337 $3.26 Million
Q1 2021

May 13, 2021

SELL
$112.98 - $319.93 $56,490 - $159,965
-500 Reduced 7.7%
5,997 $1.09 Million
Q4 2020

Feb 12, 2021

BUY
$78.74 - $139.5 $1,811 - $3,208
23 Added 0.36%
6,497 $724,000
Q3 2020

Oct 30, 2020

BUY
$79.44 - $178.51 $22,481 - $50,518
283 Added 4.57%
6,474 $701,000
Q2 2020

Aug 10, 2020

BUY
$13.86 - $83.61 $85,807 - $517,629
6,191 New
6,191 $516,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.